An immune origin of type 2 diabetes? (original) (raw)

• Winzler RJ (1960) Glycoproteins. In: Putnam FW (ed) The plasma proteins. London Academic, New York, p 309
  Google Scholar
• Cogan DG, Merola L, Laibson PR (1961) Blood viscosity, serum hexosamine and diabetic retinopathy. Diabetes 10:393–395
  CAS PubMed Google Scholar
• Bergstrand CG, Furst P, Larsson Y, Sterky G (1962) Serum haptoglobin in juvenile diabetes. Scand J Clin Lab Invest 14:629–632
  CAS PubMed Google Scholar
• Ganrot PO, Gydell K, Ekelund H (1967) Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus. Acta Endocrinol (Copenh) 55:537–544
  CAS Google Scholar
• Cleve H, Alexander K, Mitzkat HJ, Nissen P, Salzmann I (1968) Serum glycoproteins in diabetes mellitus; quantitative immunological determination of acid alpha 1-glycoprotein, Gc, alpha 2-macroglobulin and hemopexin in diabetics with and without angiopathy [article in German]. Diabetologia 4:48–55
  Article CAS PubMed Google Scholar
• McMillan DE (1970) Changes in serum proteins and protein-bound carbohydrates in diabetes mellitus. Diabetologia 6:597–604
  Article CAS PubMed Google Scholar
• Schmidt MI, Duncan BB, Sharrett AR et al (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 353:1649–1652
  Article CAS PubMed Google Scholar
• Duncan BB, Schmidt MI, Offenbacher S, Wu KK, Savage PJ, Heiss G (1999) Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 22:767–772
  CAS PubMed Google Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334
  Article CAS PubMed Google Scholar
• Barzilay JI, Abraham L, Heckbert SR et al (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384–2389
  CAS PubMed Google Scholar
• Lindsay RS, Krakoff J, Hanson RL, Bennett PH, Knowler WC (2001) Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes 50:1598–1603
  CAS PubMed Google Scholar
• Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455–461
  CAS PubMed Google Scholar
• Freeman DJ, Norrie J, Caslake MJ et al (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596–1600
  CAS PubMed Google Scholar
• Ford ES (2002) Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 155:57–64
  Article PubMed Google Scholar
• Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K (2002) White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia 45:42–48
  Article CAS PubMed Google Scholar
• Festa A, D’Agostino R Jr, Tracy RP, Haffner SM (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51:1131–1137
  CAS PubMed Google Scholar
• Thorand B, Lowel H, Schneider A et al (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg Cohort Study, 1984–1998. Arch Intern Med 163:93–99
  Article CAS PubMed Google Scholar
• Spranger J, Kroke A, Mohlig M et al (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812–817
  CAS PubMed Google Scholar
• Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25:2016–2021
  CAS PubMed Google Scholar
• Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS (2003) C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 26:2323–2328
  CAS PubMed Google Scholar
• Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693–700
  CAS PubMed Google Scholar
• Snijder MB, Dekker JM, Visser M et al (2003) Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care 26:1656–1657
  PubMed Google Scholar
• Groop L, Groop PH, Koskimies S (1986) Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 29:757–760
  Article CAS PubMed Google Scholar
• Rich SS, French LR, Sprafka JM, Clements JP, Goetz FC (1993) HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study. Diabetologia 36:234–238
  Article CAS PubMed Google Scholar
• Tuomilehto-Wolf E, Tuomilehto J, Hitman GA et al (1993) Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 307:155–159
  CAS PubMed Google Scholar
• Ghabanbasani MZ, Spaepen M, Buyse I et al (1995) Increased and decreased relative risk for non-insulin-dependent diabetes mellitus conferred by HLA class II and by CD4 alleles. Clin Genet 47:225–230
  CAS PubMed Google Scholar
• Vendrell J, Gutierrez C, Pastor R, Richart C (1995) A tumor necrosis factor-beta polymorphism associated with hypertriglyceridemia in non-insulin-dependent diabetes mellitus. Metabolism 44:691–694
  Article CAS PubMed Google Scholar
• Fernandez-Real JM, Gutierrez C, Ricart W et al (1997) The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468–1472
  CAS PubMed Google Scholar
• Fernandez-Real JM, Vendrell J, Ricart W et al (2000) Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care 23:831–837
  CAS PubMed Google Scholar
• Fernandez-Real JM, Broch M, Vendrell J et al (2000) Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517–520
  CAS PubMed Google Scholar
• Hoffstedt J, Andersson IL, Persson L, Isaksson B, Arner P (2002) The common −675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity. Diabetologia 45:584–587
  Article CAS PubMed Google Scholar
• Perez-Luque E, Alaez C, Malacara JM et al (2003) Protective effect of DRB1 locus against type 2 diabetes mellitus in Mexican Mestizos. Hum Immunol 64:110–118
  Article CAS PubMed Google Scholar
• Wolford JK, Gruber JD, Ossowski VM et al (2003) A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 78:136–144
  Article CAS PubMed Google Scholar
• Rosmond R, Chagnon M, Bouchard C, Bjorntorp P (2003) Increased abdominal obesity, insulin and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-beta1 gene. Horm Res 59:191–194
  Article CAS PubMed Google Scholar
• Escobar-Morreale HF, Calvo RM, Villuendas G, Sancho J, San Millan JL (2003) Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res 11:987–996
  CAS PubMed Google Scholar
• Illig T, Bongardt F, Schöpfer A et al (2004) Significant association of the interleukin-6 gene polymporphism C-174G and A-598G with type 2 diabetes. J Clin Endocrin Metab 89:5053–5058
  Article CAS Google Scholar
• Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610–614
  Article CAS PubMed Google Scholar
• Dong ZM, Gutierrez-Ramos JC, Coxon A, Mayadas TN, Wagner DD (1997) A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci U S A 94:7526–7530
  Article CAS PubMed Google Scholar
• Wallenius V, Wallenius K, Ahren B et al (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75–79
  Article CAS PubMed Google Scholar
• Schafer K, Fujisawa K, Konstantinides S, Loskutoff DJ (2001) Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 15:1840–1842
  CAS PubMed Google Scholar
• Ma LJ, Mao SL, Taylor KL et al (2004) Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53:336–346
  CAS PubMed Google Scholar
• Lijnen HR, Maquoi E, Morange P et al (2003) Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 23:78–84
  Article CAS PubMed Google Scholar
• Perreault M, Marette A (2001) Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138–1143
  Article CAS PubMed Google Scholar
• Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I (2000) Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20:1150–1154
  CAS PubMed Google Scholar
• Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19
  Article CAS PubMed Google Scholar
• Goldstein BJ (2003) Insulin resistance: from benign to type 2 diabetis mellitus. Rev Cardiovasc Med 4 [Suppl 6]:S3–S10
  Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432
  Article CAS PubMed Google Scholar
• Bali D, Svetlanov A, Lee HW et al (1995) Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 270:21464–21467
  Article CAS PubMed Google Scholar
• Terauchi Y, Sakura H, Yasuda K et al (1995) Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem 270:30253–30256
  Article CAS PubMed Google Scholar
• Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA (1995) Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 83:69–78
  Article CAS PubMed Google Scholar
• Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415–421
  Article CAS PubMed Google Scholar
• Erickson JC, Hollopeter G, Palmiter RD (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704–1707
  Article CAS PubMed Google Scholar
• Janson J, Soeller WC, Roche PC et al (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A 93:7283–7288
  Article CAS PubMed Google Scholar
• Stenbit AE, Tsao TS, Li J et al (1997) GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 3:1096–1101
  Article CAS PubMed Google Scholar
• Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561–572
  Article CAS PubMed Google Scholar
• Leiter EH (1997) Carboxypeptidase E and obesity in the mouse. J Endocrinol 155:211–214
  Article CAS PubMed Google Scholar
• Ren JM, Li PM, Zhang WR et al (1998) Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47:493–497
  CAS PubMed Google Scholar
• Withers DJ, Gutierrez JS, Towery H et al (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904
  Article CAS PubMed Google Scholar
• Masuzaki H, Paterson J, Shinyama H et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166–2170
  Article CAS PubMed Google Scholar
• Kim JK, Fillmore JJ, Chen Y et al (2001) Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 98:7522–7527
  Article CAS PubMed Google Scholar
• Laustsen PG, Michael MD, Crute BE et al (2002) Lipoatrophic diabetes in Irs1(−/−)/Irs3(−/−) double knockout mice. Genes Dev 16:3213–3222
  Article CAS PubMed Google Scholar
• Hribal ML, Oriente F, Accili D (2002) Mouse models of insulin resistance. Am J Physiol Endocrinol Metab 282:E977–E981
  CAS PubMed Google Scholar
• Mauvais-Jarvis F, Kulkarni RN, Kahn CR (2002) Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin Endocrinol (Oxf) 57:1–9
  Article CAS Google Scholar
• Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336
  Article CAS PubMed Google Scholar
• Baudry A, Leroux L, Jackerott M, Joshi RL (2002) Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes. EMBO Rep 3:323–328
  Article CAS PubMed Google Scholar
• Valet P, Tavernier G, Castan-Laurell I, Saulnier-Blache JS, Langin D (2002) Understanding adipose tissue development from transgenic animal models. J Lipid Res 43:835–860
  CAS PubMed Google Scholar
• Conarello SL, Li Z, Ronan J et al (2003) Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl Acad Sci U S A 100:6825–6830
  Article CAS PubMed Google Scholar
• Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860
  Article CAS PubMed Google Scholar
• Shanmugam N, Reddy MA, Guha M, Natarajan R (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52:1256–1264
  CAS PubMed Google Scholar
• Chen Y, Schneider DJ (2002) The independence of signaling pathways mediating increased expression of plasminogen activator inhibitor type 1 in HepG2 cells exposed to free fatty acids or triglycerides. Int J Exp Diabetes Res 3:109–118
  Article PubMed Google Scholar
• Morohoshi M, Fujisawa K, Uchimura I, Numano F (1996) Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954–959
  PubMed Google Scholar
• Morigi M, Angioletti S, Imberti B et al (1998) Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 101:1905–1915
  CAS PubMed Google Scholar
• Guha M, Bai W, Nadler JL, Natarajan R (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275:17728–17739
  Article CAS PubMed Google Scholar
• Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470
  Article CAS PubMed Google Scholar
• Weigert C, Brodbeck K, Staiger H et al (2004) Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor kappa B. J Biol Chem 279:23942–23952
  Article CAS PubMed Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1–8
  CAS PubMed Google Scholar
• Schiekofer S, Andrassy M, Chen J et al (2003) Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes 52:621–633
  CAS PubMed Google Scholar
• Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
  Article CAS PubMed Google Scholar
• Hammes HP, Du X, Edelstein D et al (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9:294–299
  Article CAS PubMed Google Scholar
• Petersen KF, Befroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142
  Article CAS PubMed Google Scholar
• Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671
  Article CAS PubMed Google Scholar
• Ceriello A, Falleti E, Motz E et al (1998) Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 30:146–149
  CAS PubMed Google Scholar
• Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067–2072
  Article CAS PubMed Google Scholar
• Esposito K, Nappo F, Giugliano F et al (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78:1135–1140
  CAS PubMed Google Scholar
• Krebs M, Geiger M, Polak K et al (2003) Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man. Thromb Haemost 90:422–428
  CAS PubMed Google Scholar
• Ceriello A, Quagliaro L, Piconi L et al (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701–710
  CAS PubMed Google Scholar
• van Oostrom AJ, van Dijk H, Verseyden C et al (2004) Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3. Am J Clin Nutr 79:510–515
  PubMed Google Scholar
• Vlassara H, Palace MR (2002) Diabetes and advanced glycation endproducts. J Intern Med 251:87–101
  Article CAS PubMed Google Scholar
• Peppa M, Goldberg T, Cai W, Rayfield E, Vlassara H (2002) Glycotoxins: a missing link in the “relationship of dietary fat and meat intake in relation to risk of type 2 diabetes in men”. Diabetes Care 25:1898–1899
  PubMed Google Scholar
• Taylor R (2004) Causation of type 2 diabetes—the Gordian knot unravels. N Engl J Med 350:639–641
  Article CAS PubMed Google Scholar
• Arkan MC, Hevener AL, Greten FR et al (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198
  Article CAS PubMed Google Scholar
• Stumpo R, Kauer M, Martin S, Kolb H (2003) IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes. Cytokine 24:46–56
  Article CAS PubMed Google Scholar
• Hanley AJ, Festa A, D’Agostino RB et al (2004) Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53:1773–1781
  CAS PubMed Google Scholar
• Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830
  Article CAS PubMed Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808
  Article CAS PubMed Google Scholar
• Fasshauer M, Klein J, Kralisch S et al (2004) Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 317:598–604
  Article CAS PubMed Google Scholar
• Chen W, Syldath U, Bellmann K, Burkart V, Kolb H (1999) Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 162:3212–3219
  CAS PubMed Google Scholar
• Ohashi K, Burkart V, Flohé S, Kolb H (2000) Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558–561
  CAS PubMed Google Scholar
• Ruan H, Lodish HF (2003) Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 14:447–455
  Article CAS PubMed Google Scholar
• Senn JJ, Klover PJ, Nowak IA et al (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 278:13740–13746
  Article CAS PubMed Google Scholar
• Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278–301
  Article CAS PubMed Google Scholar
• Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4–7
  Article CAS PubMed Google Scholar
• Peraldi P, Spiegelman B (1998) TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem 182:169–175
  Article CAS PubMed Google Scholar
• Rui L, Yuan M, Frantz D, Shoelson S, White MF (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394–42398
  Article CAS PubMed Google Scholar
• Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823
  PubMed Google Scholar
• Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14:561–566
  Article CAS PubMed Google Scholar
• Tracey KJ (2002) The inflammatory reflex. Nature 420:853–859
  Article CAS PubMed Google Scholar
• Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556
  Article CAS PubMed Google Scholar
• Eskandari F, Webster JI, Sternberg EM (2003) Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 5:251–265
  Article CAS PubMed Google Scholar
• Pedersen BK, Steensberg A, Schjerling P (2001) Muscle-derived interleukin-6: possible biological effects. J Physiol 536:329–337
  Article CAS PubMed Google Scholar
• Penkowa M, Keller C, Keller P, Jauffred S, Pedersen BK (2003) Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 17:2166–2168
  CAS PubMed Google Scholar
• Tomiya A, Aizawa T, Nagatomi R, Sensui H, Kokubun S (2004) Myofibers express IL-6 after eccentric exercise. Am J Sports Med 32:503–508
  Article PubMed Google Scholar
• Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK (2002) IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 283:E1272–E1278
  CAS PubMed Google Scholar
• Steensberg A, van Hall G, Keller C et al (2002) Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation. J Physiol 541:273–281
  Article CAS PubMed Google Scholar
• Nybo L, Nielsen B, Pedersen BK, Moller K, Secher NH (2002) Interleukin-6 release from the human brain during prolonged exercise. J Physiol 542:991–995
  Article CAS PubMed Google Scholar
• Pedersen BK, Steensberg A, Fischer C et al (2003) Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24:113–119
  Article CAS PubMed Google Scholar
• van Hall G, Steensberg A, Sacchetti M et al (2003) Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88:3005–3010
  Article PubMed Google Scholar
• Steensberg A, Fischer CP, Sacchetti M et al (2003) Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548:631–638
  CAS PubMed Google Scholar
• Kim HJ, Higashimori T, Park SY et al (2004) Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060–1067
  CAS PubMed Google Scholar
• Wallenius K, Wallenius V, Sunter D, Dickson SL, Jansson JO (2002) Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293:560–565
  Article CAS PubMed Google Scholar
• Scheen AJ (2004) Pathophysiology of insulin secretion. Ann Endocrinol (Paris) 65:29–36
  CAS Google Scholar
• Steppel JH, Horton ES (2004) Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Curr Diabetes Rep 4:169–175
  Google Scholar
• Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2003) Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men—report from 27 years of follow-up study. Diabetologia 46:20–26
  CAS PubMed Google Scholar
• Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50:1771–1777
  CAS PubMed Google Scholar
• Carlsson C, Borg LA, Welsh N (1999) Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140:3422–3428
  Article CAS PubMed Google Scholar
• Maedler K, Spinas GA, Lehmann R et al (2001) Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683–1690
  CAS PubMed Google Scholar
• Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 [Suppl 1]:S119–S124
  CAS PubMed Google Scholar
• Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
  CAS PubMed Google Scholar
• Deng S, Vatamaniuk M, Huang X et al (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624–632
  CAS PubMed Google Scholar
• Jansson L, Eizirik DL, Pipeleers DG, Borg LA, Hellerstrom C, Andersson A (1995) Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J Clin Invest 96:721–726
  CAS PubMed Google Scholar
• Eizirik DL, Jansson L, Flodstrom M, Hellerstrom C, Andersson A (1997) Mechanisms of defective glucose-induced insulin release in human pancreatic islets transplanted to diabetic nude mice. J Clin Endocrinol Metab 82:2660–2663
  Article CAS PubMed Google Scholar
• Moriwaki M, Itoh N, Miyagawa J et al (1999) Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus. Diabetologia 42:1332–1340
  Article CAS PubMed Google Scholar
• Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005–1029
  CAS PubMed Google Scholar
• Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115–2133
  Article CAS PubMed Google Scholar
• Maedler K, Sergeev P, Ehses JA et al (2004) Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci U S A 101:8138–8143
  Article CAS PubMed Google Scholar
• Maedler K, Fontana A, Ris F et al (2002) FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication. Proc Natl Acad Sci U S A 99:8236–8241
  Article CAS PubMed Google Scholar
• Maedler K, Storling J, Sturis J et al (2004) Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. Diabetes 53:1706–1713
  CAS PubMed Google Scholar
• Maestre I, Jordan J, Calvo S et al (2003) Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology 144:335–345
  Article CAS PubMed Google Scholar
• Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S (2002) Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85–96
  Article CAS PubMed Google Scholar
• Koshkin V, Wang X, Scherer PE, Chan CB, Wheeler MB (2003) Mitochondrial functional state in clonal pancreatic beta-cells exposed to free fatty acids. J Biol Chem 278:19709–19715
  Article CAS PubMed Google Scholar
• Schrauwen P, Hesselink MK (2004) Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53:1412–1417
  CAS PubMed Google Scholar
• Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442
  CAS PubMed Google Scholar
• Aarnes M, Schonberg S, Grill V (2002) Fatty acids potentiate interleukin-1beta toxicity in the beta-cell line INS-1E. Biochem Biophys Res Commun 296:189–193
  Article CAS PubMed Google Scholar
• Srinivasan S, Bolick DT, Hatley ME et al (2004) Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 MAP kinase pathway in diabetes. J Biol Chem 279:31930–31936
  Article CAS PubMed Google Scholar
• Altannavch TS, Roubalova K, Kucera P, Andel M (2004) Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 53:77–82
  CAS PubMed Google Scholar
• Takaishi H, Taniguchi T, Takahashi A, Ishikawa Y, Yokoyama M (2003) High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem Biophys Res Commun 305:122–128
  Article CAS PubMed Google Scholar
• Asakawa H, Miyagawa J, Hanafusa T, Kuwajima M, Matsuzawa Y (1997) High glucose and hyperosmolarity increase secretion of interleukin-1 beta in cultured human aortic endothelial cells. J Diabetes Complicat 11:176–179
  Article CAS PubMed Google Scholar
• Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145:5087–5096
  Article CAS PubMed Google Scholar
• Todaro M, Di Gaudio F, Lavitrano M, Stassi G, Papaccio G (2003) Islet beta-cell apoptosis triggered in vivo by interleukin-1beta is not related to the inducible nitric oxide synthase pathway: evidence for mitochondrial function impairment and lipoperoxidation. Endocrinology 144:4264–4271
  Article CAS PubMed Google Scholar
• Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13:114–119
  Article CAS PubMed Google Scholar
• Lipscomb MF, Masten BJ (2002) Dendritic cells: immune regulators in health and disease. Physiol Rev 82:97–130
  CAS PubMed Google Scholar
• Pittoni V, Valesini G (2002) The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev 1:154–161
  Article CAS PubMed Google Scholar
• Wick G, Perschinka H, Millonig G (2001) Atherosclerosis as an autoimmune disease: an update. Trends Immunol 22:665–669
  Article CAS PubMed Google Scholar
• Frostegard J (2002) Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev 1:233–237
  Article CAS PubMed Google Scholar
• George J, Yacov N, Breitbart E et al (2004) Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. Cardiovasc Res 62:603–609
  Article CAS PubMed Google Scholar
• Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151–159
  CAS PubMed Google Scholar
• Hayden MR (2002) Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus. JOP 3:126–138
  PubMed Google Scholar
• Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308
  Article CAS PubMed Google Scholar
• de Koning EJ, van den Brand JJ, Mott VL et al (1998) Macrophages and pancreatic islet amyloidosis. Amyloid 5:247–254
  PubMed Google Scholar
• Kubaszek A, Pihlajamaki J, Komarovski V et al (2003) Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52:1872–1876
  CAS PubMed Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
  CAS PubMed Google Scholar
• Paquot N, Castillo MJ, Lefebvre PJ, Scheen AJ (2000) No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab 85:1316–1319
  Article CAS PubMed Google Scholar
• Di Rocco P, Manco M, Rosa G, Greco AV, Mingrone G (2004) Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes Res 12:734–739
  PubMed Google Scholar
• Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R (1996) Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881–885
  PubMed Google Scholar
• Rask-Madsen C, Dominguez H, Ihlemann N, Hermann T, Kober L, Torp-Pedersen C (2003) Tumor necrosis factor-alpha inhibits insulin’s stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108:1815–1821
  Article CAS PubMed Google Scholar
• Shoelson SE, Lee J, Yuan M (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27 [Suppl 3]:S49–S52
  Article CAS PubMed Google Scholar
• Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109:II2–II10
  PubMed Google Scholar
• Zheng Z, Lee JE, Yenari MA (2003) Stroke: molecular mechanisms and potential targets for treatment. Curr Mol Med 3:361–372
  Article CAS PubMed Google Scholar
• Casserly I, Topol E (2004) Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139–1146
  Article CAS PubMed Google Scholar
• Franceschi C, Bonafe M (2003) Centenarians as a model for healthy aging. Biochem Soc Trans 31:457–461
  Article CAS PubMed Google Scholar
• Grimble RF (2003) Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care 6:21–29
  Article CAS PubMed Google Scholar
• Yucesoy B, Kashon ML, Luster MI (2003) Cytokine polymorphisms in chronic inflammatory diseases with reference to occupational diseases. Curr Mol Med 3:39–48
  Article CAS PubMed Google Scholar
• McGeer PL, McGeer EG (2001) Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 58:1790–1792
  Article CAS PubMed Google Scholar
• Duchen MR (2004) Roles of mitochondria in health and disease. Diabetes 53 [Suppl 1]:S96–S102
  CAS PubMed Google Scholar
• McCord JM (2002) Superoxide dismutase in aging and disease: an overview. Methods Enzymol 349:331–341
  CAS PubMed Google Scholar
• Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53 [Suppl 3]:S26–S36
  Article CAS PubMed Google Scholar
• Yoshida M (2003) Potential role of statins in inflammation and atherosclerosis. J Atheroscler Thromb 10:140–144
  CAS PubMed Google Scholar
• Santangelo F (2003) Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach. Curr Med Chem 10:2599–2610
  Article CAS PubMed Google Scholar
• Rosenson RS (2004) Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 173:1–12
  Article CAS PubMed Google Scholar
• Violi F, Loffredo L, Musella L, Marcoccia A (2004) Should antioxidant status be considered in interventional trials with antioxidants? Heart 90:598–602
  Article CAS PubMed Google Scholar
• Cuzzocrea S, Thiemermann C, Salvemini D (2004) Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem 11:1147–1162
  CAS PubMed Google Scholar
• Green K, Brand MD, Murphy MP (2004) Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 [Suppl 1]:S110–S118
  CAS PubMed Google Scholar
• Schmidt MI, Duncan BB (2003) Diabesity: an inflammatory metabolic condition. Clin Chem Lab Med 41:1120–1130
  Article CAS PubMed Google Scholar
• Theuma P, Fonseca VA (2003) Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis. Curr Diabetes Rep 3:248–254
  Google Scholar
• Garg R, Tripathy D, Dandona P (2003) Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. Curr Drug Targets 4:487–492
  Article CAS PubMed Google Scholar
• Haffner SM (2003) Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 92:18J–26J
  Article CAS PubMed Google Scholar
• Aldhahi W, Hamdy O (2003) Adipokines, inflammation, and the endothelium in diabetes. Curr Diabetes Rep 3:293–298
  Google Scholar
• Yudkin JS, Panahloo A, Stehouwer C et al (2000) The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type II diabetic subjects. Diabetologia 43:1099–1106
  Article CAS PubMed Google Scholar
• Sattar N, Gaw A, Scherbakova O et al (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414–419
  Article CAS PubMed Google Scholar
• Milani RV, Lavie CJ, Mehra MR (2004) Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 43:1056–1061
  Article CAS PubMed Google Scholar
• Clifton PM, Noakes M, Keogh J, Foster P (2003) How effective are meal replacements for treating obesity? Asia Pac J Clin Nutr 12 [Suppl]:S51
  Google Scholar
• Brinkworth GD, Noakes M, Keogh JB, Luscombe ND, Wittert GA, Clifton PM (2004) Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord 28:661–670
  Article CAS PubMed Google Scholar
• Marfella R, Esposito K, Siniscalchi M et al (2004) Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 27:47–52
  CAS PubMed Google Scholar
• Clifton PM (2003) Diet and C-reactive protein. Curr Atheroscler Rep 5:431–436
  PubMed Google Scholar
• Kopp HP, Kopp CW, Festa A et al (2003) Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23:1042–1047
  Article CAS PubMed Google Scholar
• Esposito K, Pontillo A, Di Palo C et al (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799–1804
  Article CAS PubMed Google Scholar
• Hanusch-Enserer U, Cauza E, Spak M et al (2003) Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 27:355–361
  Article CAS PubMed Google Scholar
• Laimer M, Ebenbichler CF, Kaser S et al (2002) Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 26:659–662
  Article CAS PubMed Google Scholar
• Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105:564–569
  Article PubMed Google Scholar
• Esposito K, Pontillo A, Ciotola M et al (2002) Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87:3864–3866
  Article CAS PubMed Google Scholar
• Heilbronn LK, Noakes M, Clifton PM (2001) Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21:968–970
  CAS PubMed Google Scholar
• Bastard JP, Jardel C, Bruckert E, Vidal H, Hainque B (2000) Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obes Metab 2:323–325
  Article CAS PubMed Google Scholar
• Straczkowski M, Kowalska I, Dzienis-Straczkowska S et al (2001) Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur J Endocrinol 145:273–280
  Article CAS PubMed Google Scholar
• Ziccardi P, Nappo F, Giugliano G et al (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804–809
  Article CAS PubMed Google Scholar
• Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B (2003) Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 148:535–542
  Article CAS PubMed Google Scholar
• Bastard JP, Jardel C, Bruckert E et al (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85:3338–3342
  Article CAS PubMed Google Scholar
• Troseid M, Lappegard KT, Claudi T et al (2004) Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 25:349–355
  Article CAS PubMed Google Scholar
• Fukuzawa M, Satoh J, Qiang X et al (1999) Inhibition of tumor necrosis factor-alpha with anti-diabetic agents. Diabetes Res Clin Pract 43:147–154
  Article CAS PubMed Google Scholar
• Akbar DH (2003) Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. Endocrine 20:215–218
  Article CAS PubMed Google Scholar
• Chu NV, Kong AP, Kim DD et al (2002) Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care 25:542–549
  CAS PubMed Google Scholar
• Carlsen SM, Waage A, Grill V, Folling I (1998) Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease. Cytokine 10:66–69
  Article CAS PubMed Google Scholar
• Ebeling P, Teppo AM, Koistinen HA et al (1999) Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with type II diabetes. Diabetologia 42:1433–1438
  Article CAS PubMed Google Scholar
• Varo N, Vicent D, Libby P et al (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation 107:2664–2669
  Article CAS PubMed Google Scholar
• Katsuki A, Sumida Y, Murata K et al (2000) Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. Diabetes Obes Metab 2:189–191
  Article CAS PubMed Google Scholar
• Jeschke MG, Einspanier R, Klein D, Jauch KW (2002) Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8:443–450
  CAS PubMed Google Scholar
• Dandona P, Aljada A, Mohanty P (2002) The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924–930
  Article CAS PubMed Google Scholar
• Dandona P, Aljada A, Mohanty P et al (2001) Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257–3265
  Article CAS PubMed Google Scholar
• Muller S, Martin S, Koenig W et al (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45:805–812
  Article CAS PubMed Google Scholar